Cancer Patients Overcharges 1000% by United Healthcare

That is not a typo! UnitedHealth Group, a major U.S. healthcare company, is under federal investigation for potential overcharging cancer patients by its pharmacy benefit manager, OptumRx. The Federal Trade Commission (FTC) is investigating claims of price gouging, sometimes exceeding 1000%, prompting concerns about patient access to affordable medications. This investigation is part of a broader FTC inquiry into pharmacy benefit manager (PBM) practices. The allegations have raised investor concerns and could lead to regulatory changes within the healthcare industry. This is the same company that CEO Brian Thompson worked for who was shot by Luigi Mangione.